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 Skin disease can affect quality of life (QoL) of teenagers in a variety of different 
ways, some being unique to this age group 
 Dermatology4specific QoL measures exist for adults and children 
 Skindex4Teen, has been the only (214item) QoL measure for adolescents  
,!	!	- 
 T4QoL is a new age4specific measure to assess QoL of teenagers suffering from 
different skin diseases 
 Items were generated using direct input from target population 
 T4QoL was developed and psychometrically analysed using both traditional classical 
test theory and modern item response theory models 
 

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*
To develop and validate a dermatology4specific quality of life (QoL) instrument for 
adolescents with skin diseases. 
.!
Qualitative semi4structured interviews were conducted with adolescents with skin disease to 
gain in4depth understanding of how skin diseases affect their QoL. A prototype instrument 
based on the themes identified from content analysis of interviews was tested in several 
stages, using Classical Test Theory (CTT) and Item Response Theory (IRT) models to 
develop this new tool and conduct its psychometric evaluation. 
&

Thirty4three QoL issues were identified from semi4structured interviews with 50 adolescents. 
A questionnaire based on items derived from content analysis of interviews was subjected to 
Rasch analysis: factor analysis identified three domains, therefore not supporting the validity 
of T4QoL as a unidimensional measure.  Psychometric evaluation of the final 184item 
questionnaire was carried out in a cohort of 203 adolescents. Convergent validity was 
demonstrated by significant correlation with Skindex4Teen and CDLQI or DLQI. The T4QoL 
showed excellent internal consistency reliability: Cronbach’s α=0.89 for total scale score and 
0.85, 0.60, and 0.74 respectively for domains 1, 2 and 3. Test4retest reliability was high in 
stable subjects. T4QoL showed sensitivity to change in two sub4groups of patients who 
indicated change in their self4assessed disease severity.  


Built on rich qualitative data from patients, the T4QoL is a simple and valid tool to quantify 
the impact of skin disease on adolescents’ QoL; it could be used as an outcome measure in 
both clinical practice and clinical research.  
 


Page 6 of 31British Journal of Dermatology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
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
There are several specific aspects of quality of life (QoL) affected by skin disease in 
adolescence, highlighting the importance of having an age4specific QoL tool.
1
 The 
Dermatology Life Quality Index (DLQI),
2,3
 designed for adults aged over16 years, contains 
some items irrelevant to younger adolescents. The Children's Dermatology Life Quality 
Index (CDLQI),
4,5
 designed for children aged 4416 years, is not focussed on specific teenage 
issues. The overlap of CDLQI and DLQI scores highlights the need for an adolescent specific 
tool.
6
  Self4image, influence of peers and new friendships are of paramount importance to 
teenagers,
1,7
 aspects under4represented in existing dermatology4specific tools. The impact of 
skin diseases is predominantly based on adolescents’ subjective perceptions of their 
condition, rather than on objective clinical measures.
8
  Other QoL measures focussed on the 
concerns of adolescents include acne specific measures, as acne primarily affects this age 
group.
9,10
  However when measuring QoL in adolescence, researchers have generally used 
measures designed to be used across childhood.
11,12
  In a systematic review of the 
measurement of QoL in adolescents with psoriasis, measures used were a general pediatric 
measure, PedsQL 4 or the CDLQI.
13
 
Skindex4Teen,
14
 has two domains: physical symptoms and psychosocial functioning. The 
items were derived from the pre4existing adult tool Skindex, literature review and feedback 
from experts. Unfortunately, there was no direct input from adolescent patients at the time of 
item generation, though the questions were later reviewed by a patient panel.  The aims of 
this study were to use information directly from adolescents, to give a comprehensive insight 
into the impact of skin diseases on their QoL in order to develop and psychometrically 
validate an adolescent4specific QoL instrument.  
 
.!
This study, undertaken at the University Hospital of Wales, Cardiff from 200842012, was 
approved by Cardiff and Vale NHS Trust and South East Wales Local Research Ethics 
Committee. Written informed consent was obtained from participants aged 18419 years, or 
from a parent (with assent) if aged <18 years. All information was kept confidential. 
Inclusion criteria included patients aged 12419 years, able to understand and read English, 
suffering from a diagnosed skin disease, able to give assent or written informed consent and 
not suffering from concomitant illness affecting QoL. The exclusion criteria included patients 
with significant co4morbidities. In practice this meant diseases such as physical and mental 
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disabilities, malignancies, or severe chronic disease, such as severe rheumatoid arthritis.  In 
all phases of this study, patients were recruited by consecutive sampling methodology, a 
convenience sampling approach.
15
  The study was conducted in five stages: conceptualisation 
and development of a conceptual framework; qualitative interviews; item generation; scale 
refinement and item reduction; and psychometric evaluation of the final instrument (Figure 
1).  
 
Conceptual framework 
The impacts of skin diseases on adolescents were identified
1,4,7,8 
and selected for inclusion in 
the preliminary hypothesized conceptual framework. The primary impacts included impacts 
on functional behaviour (i.e. both physical and psychosocial), changing or modifying daily 
schedules (missing work or school), wearing makeup or clothes to conceal appearance 
concerns, difficulties concentrating, feeling angry or frustrated, impacts on relationships with 
family and friends, and difficulties playing sports. Figure 2 shows the hypothesized 
conceptual framework for quality of life impacts in adolescents with skin disease. 
 
Qualitative interviews, item generation and comprehensiveness testing 
Semi4structured interviews were conducted with teenage patients and transcribed verbatim. 
Patients were asked to describe ways their lives had been affected by their skin disease. This 
information was used to draft an instrument with 54point response categories, “T4QoL”, 
which was pilot4tested in a new cohort of teenagers for cognitive debriefing and to test 
content and face validity. Qualitative feedback was given by study participants and the four 
experts concerning item relevance, language clarity, completeness and scaling.   
The comprehensiveness of the tool was assessed qualitatively during the second stage of item 
generation while conducting the face and content validation of the draft questionnaire. 
Twenty adolescent study subjects were recruited who gave their opinion about the relevance, 
wording, and clarity of individual items, and "whether anything that they thought was 
relevant but was missing from the questionnaire". They were also asked whether there were 
any items that should be omitted or altered.  Qualitative feedback was also sought from four 
dermatology staff members with experience in treating young adults with skin conditions 
concerning the format, content, relevance of questions, clarity, wording and response 
categories. These experts were also asked whether they thought any important aspects were 
not covered by the draft questionnaire.  Items were removed, substituted and merged, 
resulting in the second T4QoL version.  
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Scale refinement and item reduction  
The second T4QoL version was tested in a new patient cohort to refine the instrument by 
applying classical test theory (CTT) and item response theory (IRT) of Rasch modelling. 
Rasch analysis was carried out using RUMM 2030 software to assess overall model fit, item 
responses, individual item fit and differential item functioning (DIF). Factor analysis 
identified the factor structure underlying the instrument items. Further reduction of items and 
of response categories yielded the final T4QoL version (Appendix 1).  
 
Psychometric evaluation of the final instrument 
The psychometric properties of T4QoL were assessed including validity, reliability and 
sensitivity to change. Convergent and construct validity was assessed by asking subjects to 
complete the T4QoL and the DLQI (if 16419 years), or CDLQI (if 12416 years), Skindex4
Teen and a global question (GQ) on self4assessed disease severity on 0410 scale, with 0 
indicating clear skin and 10 most severe disease. Spearman rank correlation was used to 
assess the correlation coefficient between T4QoL and the three questionnaires. Correlation 
coefficient represents an effect size that describes the strength of relationship between two 
variables and its value ranges from 041.  These effect sizes are interpreted as follows: 040.19 
= very weak; 0.240.39 = weak; 0.440.59 = moderate; 0.640.79 = strong; 0.8041.0 = very strong 
correlation.  
 
Cronbach’s α was used to assess the internal consistency reliability. There are different 
reports with regard to acceptable level of Cronbach's α for measurement scales, ranging from 
0.740.9.
16,17,18
  A value of 0.7 has been recommended as acceptable.
16
  On the other hand a 
value of α above 0.9 may indicate item redundancy.  An intraclass correlation coefficient 
(ICC) value between 0.60 and 0.74 is considered good whereas a higher value than 0.75 
constitutes excellent.
19
  For any scale to be useful a minimum ICC of 0.6 is required.
20
 
 
Construct validity of the instrument was assessed by testing a number of a priori hypotheses: 
that there will be high correlation between the T4QoL and an instrument with similar 
construct i.e. Skindex4Teen and moderate to high correlation with other dermatology4specific 
QoL instruments 4 the DLQI and CDLQI. We also hypothesised a low4moderate correlation 
between T4QoL and self4assessed disease severity assessed by GQ based on previous 
experience.
14,21,22 
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To assess test4retest reliability, a sub4group of consecutive study participants were given a 
second set of questionnaires to complete at home 347 days after the first visit and return using 
a stamped reply envelope. This short time period was to ensure that the skin condition 
severity had not changed significantly but at the same time to minimise the chances of recall 
of previous responses.  Participants received a telephoned reminder. Only those with 
unchanged GQ score or a difference of ± 1 were included in the analysis. Test4retest 
reliability or stability was tested using ICC for the overall T4QoL scale and three sub4scales.  
Assessment of T4QoL's sensitivity to change was based on testing the a priori hypothesis that 
"there will be change in patients' T4QoL scores following changes in their disease severity as 
assessed by the GQ". In order to test this, subjects were contacted 143 months following 
completion of stage I. Patients who participated in stages I and II were posted a pack with a 
stamped reply envelope. Only subjects with a GQ score that changed by ± 2 points were 
included in the analysis.  Wilcoxon signed rank test was used to assess the difference in T4
QoL scores on two occasions in two subject groups: improved and worsened.  When testing 
sensitivity to change, what matters is the validity of the change scores, rather that the 
magnitude of the change scores, as a high magnitude of change gives little indication of the 
ability of an instrument to detect change over time. Although ES and SRM values are not 
appropriate measures for this matter, we report them in order that comparisons may be drawn 
with similar data reported in the description of other measures. 
 
Responsiveness of the T4QOL was analysed by compar ng T4QoL score changes across 
patient groups to DLQI and CDLQI score changes. Patients were divided into three groups 
(improved, no change, and worsened) according to score changes from visit 1 to visit 3, on 
the GQ score, DLQI and CDLQI.  
 
A GQ score change of ≥ 2 or ≤ 42 represented worsened or improved, respectively, whilst 
scores between > 42 and < 2 represented no clinically relevant change i.e. no change. For the 
DLQI and CDLQI, a score change of ≥ 3 or ≤ 43 represented worsened or improved, 
respectively, whilst scores between > 43 and < 3 represented no change (i.e. clinically non4
significant change). The cut4off for the DLQI is less than the minimal clinically important 
difference (MCID) of 4
23
 and is similarly likely to be less than the MCID for the CDLQI. 
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Comparator instruments 
 
Skindex4Teen  
Skindex4Teen is a self4administered 214item dermatology specific QoL instrument for 
teenagers with different skin diseases.
14
  The questions ask the respondent about the impact 
of their skin condition on various aspects of QoL during the previous 4 weeks period. Each 
item is scored on a 54point scale: Never, Rarely, Sometimes, Often and All the time. Scores 
of the individual items (044) are added to yield to a total score (0484); the higher the score, 
the greater the QoL impairment.
Dermatology Life Quality Index (DLQI)  
The DLQI is one of the most commonly used QoL instruments for adult patients (16 years 
and above) with skin disease.
2,3
  It is a self4administered, user4friendly questionnaire with a 
mean completion time of around 2 minutes.
24
  It consists of 10 questions concerning patient 
perception of the impact of skin disease on different aspects of patient’s health related QoL 
over the last week. The items of the DLQI encompass aspects such as symptoms and feelings, 
daily activities, leisure, work or school, personal relationships and the side effects of 
treatment. Each item is scored on a 44point scale: Not at all/Not relevant, A little, A lot and 
Very much. Scores of the individual items (043) are added to yield to a total score (0430); 
higher scores mean greater impairment of patients’ QoL.  
Childrens Dermatology Life Quality index (CDLQI) 
The CDLQI is an instrument specifically designed for children between 4 and 16 years of 
age, to measure the impact of skin disease on their QoL.
4,5
  There are text
 
and text plus 
cartoon
25
 versions of the CDLQI. The questionnaire was designed to be completed by the 
child, with the help of an adult, preferably the child’s parent. Each item is scored on a four 
point scale: Not at all, A little, Quite a lot, Very Much. Scores of the individual items (043) 
are added to give a total score of from 0 to 30; the higher the score, the greater the 
impairment of child QoL.  
Statistical analysis 
Statistical analysis was performed using the Statistical Package for the Social Sciences 
(SPSS, versions 15.0, 16.0, 17.0 and 22.0). Probability of type I error was set at 5% (i.e. 
p<0.05). 
Page 11 of 31 British Journal of Dermatology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 
&

In total 426 adolescent patients with skin diseases were recruited from the dermatology 
outpatient clinics, University Hospital of Wales (Table 1). Four expert dermatology staff 
members also took part. 
 
/0 	
	 "			


Direct input from adolescent patients with skin diseases was gained through face to face 
qualitative interviews.
1
  Semi4structured interviews were conducted with 50 subjects (M=17, 
F=33, mean age 16 years, range=12418). Patients were asked: ‘Can you tell me all the ways 
you can think of how your skin condition has affected your life?’Interviews were transcribed 
verbatim. Saturation point was reached at interview number 32, however, 18 further 
interviews were conducted. Twelve main themes were generated (Table 2). Various aspects 
of QoL identified by thematic analysis of interview scripts using the “grounded theory” 
formed the basis of the new instrument, building on the preliminary hypothesised conceptual 
framework (Figure 2) as described below.

10 '	

Content analysis of interview transcripts identified 32 items that formed the prototype 
instrument. This represented eight distinct QoL domains: psychological, social, physical, 
relationships, leisure, studies/jobs/career, support, and impact on daily activities. The items 
asked adolescents the impact of their skin condition on their current QoL. A 54point (044) 
adjectival scale was chosen to score each item: Never = 0; Rarely = 1; Sometimes = 2; Often 
= 3; and Always = 4. In the prototype there was an additional scoring category “Not 
relevant”.  Items described by participants as “Important” are listed in Table 2. Most of these 
items appeared in the first 324item draft questionnaire.  During subsequent stages of item 
refinement, several items were removed because they did not meet the statistical criteria, 
even though from the face value perspective they appeared important and relevant to the 
conceptual model. 
Cognitive debriefing, face and content validity of the prototype instrument were carried out 
with a new cohort of 20 adolescents (Table 1). All 20 participants (100%) responded ‘Yes’ to 
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being happy to complete the questionnaire, found it relevant and said they would be willing 
to complete such a measure every clinic visit. All 20 (100%) stated the questionnaire was not 
time consuming. Concerning content and face validity, 80% reported that the questionnaire 
was “easy to understand”, 70% thought it the right length and no items were vague or 
repetitive.  
Four dermatology staff members experienced in treating adolescents commented on the 
prototype instrument, using a study4specific questionnaire to rate it for format, language 
clarity, completeness, relevance and scaling. No matters of concern were raised. Following 
the feedback from the two cohorts, two items were removed and wording of a few items 
simplified to improve readability. This led to a 304item second version of the T4QoL. 
20 #	


The aim was to test the 304item T4QoL version for further refinement, including test of 
unidimensionality, on a new cohort of adolescent patients using Rasch modelling. 
 
In total 155 adolescents attending the dermatology department were invited to participate: 
one declined for personal reasons and one with other health issues was unsuitable. All 
patients, with 23 different skin conditions (Table 1), completed the T4QoL. All were 
evaluable and psychometric analysis was carried out. Figure 3 shows the distribution of T4
QoL scores of individual items in 153 participants. The mean item scores were (Figure 3): 
self4consciousness (2.4); thinking a lot about the condition (2.4); need to cover up affected 
areas (2.2); feeling annoyed (2.1); relationships with family (0.3); lack of support from 
healthcare staff (0.3) and family/friends (0.2). Results of the factor analysis of the original 
304item questionnaire, with factor loadings, are given in Supplementary File 1. 
 
Rasch analysis was carried out on the 304item version T4QoL data from 153 adolescent 
patients using Rasch Unidimensional Measurement Model (RUMM) software version 2030, 
with data imported from SPSS version 15. Rasch analysis found significant 
multidimensionality and did not support the validity of the T4QoL as a unidimensional 
measure of QoL impairment (Chi Square Probability=0.0001). Factor analysis was carried 
out to assess the level of multidimensionality. The Scree plot (Figure 4) showed the “elbow” 
effect, seen when a scale is measuring more than one domain or factor. The initial 
Eigenvalues, obtained from the Scree plot, were compared with Random Eigenvalues. Three 
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of the observed Eigenvalues were greater than the generated Eigenvalues, implying the 
presence of three domains (Table 3). Each of the domains was then subjected to Rasch 
analysis individually. The finalised domain 1 was approved on the 3
rd
 attempt of Rasch 
analysis, after the sequential removal of items 19, 7 and 17. These items were identified as 
mis4fitting the Rasch model, causing skewing of other items and preventing the domain being 
unidimensional. After the removal of these 3 items the item4reduced domain 1 proved to be 
unidimensional. When considered separately after the removal of the items 19, 7 and 17, all 
domains showed adequate fit to the model (Chi Square Probability=0.36, 0.08, 0.11 for 
domains 1, 2 and 3 respectively), good person separation (40.846, 41.535, 42.084 for domains 
1, 2 and 3 respectively), good internal consistency (α=0.91, 0.782, 0.813 for domains 1, 2 and 
3 respectively) and no significant differential item bias for gender or age. 
 
Inspection of the response options for the T4QoL revealed issues regarding response category 
ordering. Disordered thresholds indicated the failure of respondents to use the response 
categories in a manner consistent with the level of trait being measured. Disordering of 
thresholds occurred due to respondents having difficulty discriminating between 5 response 
options. Too many response options were available and the response option labelling caused 
confusion. Substantial disordering was identified for some items, e.g. items 5 and 11. The 
categories “rarely”, “sometimes” and “often” were therefore replaced by a single category 
“occasionally”, resulting in the 34response scale “Never”, “Occasionally” and “Always”. On 
completion of Rasch modeling, seven items were removed from the 304item T4QoL version 
based on low item4total correlation and location for person in order to yield a perfect fit. 
Further adjustments were made to resolve the tension between mathematical modeling and 
qualitative interview data: four items were removed and two items with similar themes 
merged. This resulted in the final 184item T4QoL version (Appendix 1) scored using the 
scale: Never=0; Occasionally=1; Always=2. Scores of individual items are added to give a 
maximum score of 36; the higher the score the greater the QOl impact.  Scores can also be 
calculated for the 3 sub4scales or domains: Self4image (items 148) with score range=0416; 
Physical well4being and future aspirations (items 9412, score range=048); Psychosocial 
impact and relationships (items 13418, score range=0412).  

30 4!!	

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The final stage involved psychometric testing of the 184item T4QoL to assess validity, 
reliability and sensitivity to change, primarily employing CTT techniques.  
 
3	
A new cohort of 203 patients was recruited from the dermatology department outpatient 
clinics with the same inclusion criteria (Table 1).  Mean item scores are shown in Figure 5. 
The items related to self4image such as “think a lot about skin”, “need to cover up”, and 
“self4consciousness” were the most highly scored items, whereas the lowest scored items 
were “effect on intimate relationships” and “relationships with friends”. This distribution of 
item scores was also reflected in the mean domain scores with domain 1Self4image) having 
the highest mean score (mean score=7; range 0416) followed by domain 3 (Psychosocial 
impact and relationships) (3.4, 0412) and domain 2 (Physical well4being and future 
aspirations) (1.7, 048).  Female subjects generally scored higher than male subjects in 
domains 1 (self image, p<0.0001) and 3 (psychosocial and relationships, p=0.006) as well as 
in overall mean score (p=0.0001) but not significantly differently in domain 2 (physical well4
being and future aspirations).  Mean completion time for T4QoL (n=156) was 78 seconds 
(SD=29.1) and for Skindex4Teen (n=156) was 129 seconds (SD=46.5, p<0.0001). Table 4 
shows mean scores for the six most common skin conditions reported. 
3)+			

Once Rasch analysis had confirmed multidimensionality underlying the items of the T4QoL, 
we carried out exploratory factor analysis. Three factors had been identified from the initial 
factor analysis of the 304item draft questionnaire. Further factor analysis was carried out on 
the 184item final version: this confirmed the presence of three factors with eigen values 
>1.00, with the first factor accounting for 38.8% of total variance whereas the three factors 
together accounted for 55.2% total variance; the eigen values of these were 6.98, 1.67 and 
1.29 respectively. Although all items in factor 1 clustered quite logically under the domain of 
"self4image", there were some complex factor loadings for the other two factors. This is 
reflected in the way these factors are labelled: factor 2 items cover "physical well4being and 
future aspiration" and factor 3 items cover "psychological impact and relationships”The 184
item T4QoL had high internal consistency reliability with Cronbach’s α of 0.89, though lower 
for individual domain scores (domains 1, 2 and 3= 0.85, 0.60, 0.74 respectively).  
3 	
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The construct validity of T4QoL was demonstrated by successfully proving the a priori 
hypotheses: the convergent validity was assessed by correlating the mean total T4QoL score 
with that of Skindex4Teen, DLQI (subjects aged 16419 years), CDLQI (subjects <16) and 
self4assessed disease severity GQ score. Significant correlations were seen with all 
comparator scales, the highest with Skindex4Teen (r=0.83 p<0.0001), a scale of similar 
construct to T4QoL, followed by slightly lower but still high correlations with CDLQI 
(r=0.75, p<0.0001) and DLQI (r=0.74, p<0.0001). There was a moderate correlation with 
patients' self4assessed disease severity, assessed by GQ (r=0.50, p<0.0001). 
 
3&
	)

For assessment of test4retest reliability, in total 61 (30% of 203) patients agreed to participate 
and completed the second set of questionnaires after a mean of 7.2 days (SD=6.5). Only T4
QoL data is presented here. The value of ICC was highest for the total T4QoL mean 
score=0.91 (95% CI=0.8740.94) follow d by domain 1=0.9 (95% CI=0.8640.94) domain 
2=0.76 (95% CI=0.6540.84) and domain 3=0.74 (95% CI=0.640.83).  
3#!	
For assessment of sensitivity to change, 41 completed questionnaires (20.2%) were returned 
(mean time interval=122.5 days, SD=81). Thirty had a GC score decrease, indicating 
improvement in their self4assessed disease severity, and 11 had an increase indicating 
deterioration. In the “improved” subgroup, there was significant change in the total T4QoL 
and each of the three domain scores (Supplementary File 2). In the individuals with GC score 
increase, there was significant change in the GQ score, and general increase in two out of 
three domains scores and total T4QoL scores, however, this change did not reach statistical 
significance (Supplementary File 2). There was an overall change in the T4QoL total scale 
score with a standardised response mean (SRM) of 0.38 and effect size (ES)=0.34, both 
indicating low4moderate effect size.  
In the analyses anchored on GQ score change, the ‘improved’ and ‘worsened’ groups showed 
moderate to large change in comparison with the ‘no change’ group (Supplementary File 3). 
The magnitude of score change in the improved group was larger than in the worsened group 
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e.g. standard response mean (SRM) for T4QoL total score was 40.68 in improved group, 4 
0.09 in the ‘no change’ group, and 0.33 in the ‘worsened’ group. Similar results were 
obtained from the other responsiveness metrics. Results based on DLQI and CDLQI as 
anchors are consistent with findings from GQ anchor. As expected, change in T4QoL scores 
showed strong correlation with score changes in related PROs i.e. DLQI (rho = 0.44), the 
CDLQI (rho = 0.66) and the SkindexT total (rho = 0.73) (Supplementary File 4). These 
findings supported the a priori hypothesis that T4QoL is sensitive to change. These findings 
supported the a priori hypothesis that T4QoL is sensitive to change. 
Overall, the current results suggest that the T4QoL is capable of detecting meaningful 
changes in the patient's condition 4 whether worsening or improving. Expected moderate to 
strong correlations between the change scores on the T4QoL and that on other related PRO 
measures provide further support for the responsiveness of the T4QoL. 
 
50(	

 
5a) Confirmatory Factor Analysis model (Supplementary File 5) 
 
A confirmatory factor analysis (CFA) model where the T4QoL items (18 items) were 
hypothesised to have a loading on one of the three domains was estimated (Supplementary 
File 6, standardised factor loadings). Residual variances for latent variable were fixed to 1. 
The results on the overall model fit were mixed. The Chi4square test, root mean square error 
of approximation (RMSEA), and Tucker Lewis Index (TLI) indicate a poor fit. On the other 
hand, standardised root mean square residual (SRMR) and the comparative fit index (CFI) 
suggest an acceptable fit.  All factor loadings were significant: 0.49 to 0.78 for self4image, 
0.4 to 0.71 for physical well4being and 0.42 to 0.71 for psychological impact and 
relationships. Residual variances for all items were positive. Covariance among the three 
domains was high, ranging from 0.62 to 0.94. 

5b) Bi4factor model 
 
A bi4factor model where the T4QoL items were hypothesised to have a loading on one of the 
three domains and an additional general factor (overall) was estimated (Supplementary File 7: 
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Standardised factor loadings). Similar assumptions as in the CFA analysis were made, except 
for an additional assumption of orthogonality i.e. the exogenous latent variables were 
assumed to be uncorrelated. 
 
The results on the overall model fit were mixed. The Chi4square test, RMSEA, and TLI 
indicate a poor fit. On the other hand, SRMR and the CFI suggest an acceptable fit. Across all 
metrics, the bi4factor showed a better fit in comparison to the CFA model without a general 
factor. All factor loadings to the general factor as well as to the three domains were 
significant. The loadings ranged from 0.30 to 0.75 for the general factor, 0.1 to 0.51 for self4
image, 0.16 to 0.74 for the physical well4being and 4 0.52 to 0.37 for psychological impact 
and relationships. Two items (T4QoL questions 13 and 14) showed negative loadings. 
Residual variances for all items were positive.  
 
5c) Comparison of model fit – CFA versus bi4factor model 
 
Overall model fit statistics suggest a slightly better fit for the bi4factor model. This is 
confirmed by a chi4square test (chi4statistic diff. = 123.5, df = 15, p < 0.001).In the bi4factor 
model all item loadings to the general factor are greater than loadings to the individual 
domains. Overall, the results from the CFA and bi4factor model support that a total score can 
be calculated despite the multidensionality of T4QoL. 

(
The first part of this study was exploratory; qualitative enquiry was made to identify different 
aspects of adolescents’ QoL affected by skin diseases. Many were distinct from adults and 
children and not appropriately captured by existing QoL tools for adults or children. For 
example, one of the major themes identified was related to pre4occupation with self4image. 
The second part of the study was the development of a dermatology4specific QoL instrument 
for adolescents, “T4QoL”©. The initial qualitative information formed the basis for 
conceptual framework of this age4specific instrument.  
 
Both the traditional CTT and the modern IRT of Rasch modeling techniques were used in the 
development, refinement and psychometric evaluation of this instrument.
26
  Rasch modeling 
is considered the most efficient means of establishing unidimensionality of a measure and 
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also for removing the items with weak psychometric performance. Application of Rasch 
modeling during the refinement stage of T4QoL resulted in removing some of the problematic 
items to yield a robust tool for easy administration and minimal respondent burden.  
Application of Rasch analysis to data in stage 3 (n=153) also demonstrated that T4QoL does 
not fulfil the criteria of unidimensionality and three domains were identified. The presence of 
three domains or sub4scales is further supported by results of principal component analysis in 
stage four. Further analysis using a bi4factor model supported the use of a total score. 
Furthermore, the variance explained by the first factor was more than 20%,
27,28
 suggesting 
that a total summary score could be used.  Ideally the three domains should be scored 
separately, but if someone wished to use a total summary score based on their specific need 
for research or clinical use, then we believe this could also be justified based on published 
criteria, as stated above. A similar provision to use a summary score for two well4identified 
domains (psychosocial functioning and physical symptoms) has also been given for Skindex4
Teen.
14
 
 
The T4QoL items enquire about current impact. This reduces respondent burden by avoiding 
need to recall, encourages greater accuracy and improves usefulness in clinical trials and 
routine practice. Having only three response options further reduces respondent burden. 
Overall, the psychometric properties are promising. There was high but not too high
29
 
internal consistency reliability (Cronbach’s α) of the total scale i.e. 0.89. The values ranged 
from 0.640.84 for the three individual domains. The decreasing magnitude of α possibly 
reflects that Cronbach’s α is related directly to the number of scale items.
16,26
  Assessment of 
test4retest reliability demonstrated stability of the measure when the skin condition remained 
unchanged. Of the four comparator measures used to assess convergent validity, the strongest 
correlation was between T4QoL and Skindex4Teen (r=0.83): they have similar constructs and 
are aimed at the same population. The lowest but still significant correlation (r=0.5) was seen 
with self4assessed disease severity, GQ.  In psoriasis there is stronger association between 
QoL and self4assessed disease severity compared to clinically assessed severity.
30
  T4QoL 
seems to be sensitive to change both at the scale and domain level.  The change was 
significant in the improved patients: it did not reach significance level in those with 
worsening of their disease severity, possibly related to the small sample size. Further larger 
sample size studies are required.  
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The only other age4specific QoL instrument available for adolescents with skin disease is the 
214item questionnaire Skindex4Teen.
14
  The T4QoL and Skindex4Teen correlation coefficient 
value was higher than for the DLQI or the CDLQI, as expected given their similar construct. 
There were other similarities between the findings of the final validation stage of our study 
and that of Smidt et al.
14
 The five commonest conditions in both were acne, atopic eczema, 
moles, psoriasis and warts with the highest mean QoL score (i.e. greatest impact) for eczema. 
Rasch analysis demonstrated both instruments to be multidimensional, with two domains for 
Skindex4Teen and three for T4QoL.  The main difference between T4QoL and Skindex4Teen 
is the way that the items were generated.  Skindex4Teen items were based on pre4existing 
Skindex questions designed originally for adults, a literature review and expert opinion.
14
  T4
QoL questions were all based on in4depth face4to4face interviews with the target adolescent 
population.
1
  In4depth interviews with relevant subjects is a critical step in item generation 
and scale construction since these give valuable first hand insight.
31
  This step is considered 
essential by the Federal Drugs Agency and European Medicines Agency in their PRO 
guidelines.
32
  The other major differ nce is the much shorter mean completion time for T4
QoL (78 seconds) compared to Skindex4Teen (129 seconds).  Reasons may include the 
greater number of questions and response categories in Skindex4Teen (21 and 5) compared to 
T4QoL (18 and 3).  Assessment length and ease of responding are main determinants of 
respondent burden.
31
 The recall period can also affect the time taken to complete questions. 
For T4QoL, “current” time is used, more straightforward than having to think about the last  
four weeks as required by Skindex4Teen. Using this “current” time frame may hopefully 
make T4QoL more responsive to change over time.   
 
	!
The study participants included adolescents from a secondary4referral practice and so is not 
representative of the wider population, introducing selection bias. Patients were not recruited 
in primary care or from inpatients. Not all adolescents with skin disease are health4care 
seeking, these results may therefore not be generalizable to all adolescents with skin disease. 
Most participants were white Caucasians (87.6%), and there was under4representation of 
adolescents with different religious beliefs, cultural values and ethnic backgrounds.  The 
sample sizes for Rasch measurement (n=153) and responsiveness (n=41) are slightly less than 
the recommended 10 subjects per item:
33
 a larger sample size would have increased the 
reliability of the results. A small sample size may risk masking misfit of the data to the Rasch 
model.  A larger data set would have ensured a more accurate person4item distribution, 
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enabling better understanding of how well targeted the T4QoL is for the patient population. In 
this Rasch analysis, only tests of DIF for gender and age were carried out. The subscales may 
produce bias between cultural groups and different types of skin disease. These will need to 
be further assessed for DIF. 
 
We sought to recruit patients with both acute and chronic skin conditions in order to develop 
a tool applicable to patients with a wide range of conditions.  However the mean duration of 
skin conditions was 5.4 years, indicating that the sample had a predominance of more chronic 
skin conditions.   
 
A larger, more heterogeneous sample would have increased the representativeness value of 
our data and not all aspects of validation of T4QoL have yet been established:
34
 There are 
several properties of QoL measurement instruments that should ideally be demonstrated to 
meet the highest standards of instrument development.  Both et al
35
 have defined these as: 
Validity (conceptual, construct and convergent), Interpretability (Norms, categorisation and 
minimal clinically important difference), Reliability (Internal consistency, retest reliability), 
Structure, Responsiveness, Item bias, cultural issues (Translation, cultural equivalence), 
Administrative burden and Alternative forms. At this stage in the development of T4QoL the 
following have been met: Validity, Reliability, Structure, Respondent burden, Administrative 
burden. 
During the recruitment process no record was kept of the total number of patients attending 
the clinic or who were invited to take part but did not do so.  There was no control group and 
so it is unclear whether the results are specific to skin disease or the issues can be generalised 
to adolescents with non4dermatological conditions. Nevertheless, disease specific 
questionnaires are not applicable to non4disease controls. In addition, response bias is another 
limitation that is shared by most questionnaire4based studies.  
 

 
 
This study confirms that skin conditions have a great impact on adolescent QoL.
1,36
  Based on 
first4hand information directly derived from the target population and within a conceptual 
framework, T4QoL is a compact, easy to understand and administer measure, with potential 
for clinical practice, where measurement has many possible benefits.
37
  Although some of the 
items in T4QoL arguably could be applied to adult or children populations, many questions 
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have a clear adolescent focus and relevance, making it distinct from adult and children QoL 
measures and reflecting the specific aspects of the transitional life phase of young adults. 
Preliminary validation results are promising adding to the potential of T4QoL to allow 
reliable and accurate assessment of QoL of adolescents with a wide range of skin afflictions.   
Data from T4QoL may be able to influence treatment plans and care strategies for individuals 
and could be used in outcome research such as in clinical trials. The next challenge is 
determining the cultural and linguistic equivalence of the measure for use in wider global 
adolescent populations. 

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Table 1: Demographic details of study participants  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 S14
Conceptualisation 
S24Item 
generation 
S34Scale 
refinement 
S44Psychometric 
testing 
n 50 20 153 203 
Males (%) 34 40 45.8 56.7 
Females (%) 66 60 54.2 43.3 
Mean age (yrs) 16 16.5 16.5 16.2 
Caucasians (%) 92 95 87.6 86.2 
Students (%) 86 75 95.5 88.7 
Living with family (%) 98 85 98 94 
No. of skin diseases (n) 10 5 23 25 
Mean duration of skin 
disease (yrs) 
7.2 7.7 5.5 4.7 
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Table 2: Quality of life aspects identified from interviews with 50 adolescents with skin diseases, 
showing 12 main themes 
Domains and frequency  
(n, %) 
Dimensions and frequency  
(n, %) 
1. Social impact  37, 74%  Avoid going out in public  16, 32% 
 Strangers 21, 42% 
 More withdrawn/isolated 3, 6% 
 Effect on friendships/relationships 19, 38% 
2. Leisure activities/ 
Hobbies 
37, 74%  Avoid swimming 24, 48% 
 Use of communal facilities  2, 4% 
 Effect on other sporting activities 12, 24% 
3. Holidays 7, 14%  Affects holiday 7, 14% 
4. Support from family 
and friends 
21, 42%  Support from family and friends 21, 42% 
 
5. Impact on education, 
interviews & 
Employment  
23, 46%  Education, interviews and Employment 23, 46% 
6. Impact on daily 
activities 
26, 52%  Washing and shaving 7, 14% 
 Disrupt sleep 13, 26% 
7. Need to cover up the 
affected skin, e.g. 
make-up 
12, 24%  Applying make-up - taking extra time 12, 24% 
8. Psychological impact  44, 88%  Anger 13, 26% 
 Comments and staring from peers and 
public 
 
 Self-conscious  
 Low confidence  
 Annoyed 14, 28% 
 Embarrassment  2, 4% 
 Spots, unclean 1, 2% 
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 Feeling different 2, 4% 
 Condition always on mind 4, 8% 
 Mood changes  
 Feeling down 12, 24% 
 Being judged  12, 24% 
9. Physical impact- 
disease related 
32, 64%  Symptoms e.g. pain, discomfort, itching  32, 64% 
10.Side-effects from 
treatment 
17, 34%  Dry lips, dry skin, skin irritation, painful 
skin 
17, 34% 
11.Compliance issues 
and burden on 
managing the disease 
11, 22%  Finding medicines hard to take 
 Continuous trips to clinic- time 
consuming 
 Applying/taking medication time 
consuming 
11, 22% 
12.Clothing  27, 54%  Material 3, 6% 
 Style 21, 42% 
 Colour 1, 2% 
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Table 3. Items included in the three domains of the draft 30-item T-QoL . 
Qn 
No. 
Domain 1 Qn 
No. 
Domain 2 Qn 
No. 
Domain 3 
1 Self-conscious 21 Affect studies/job 5 Annoyed 
2 Upset 22 Concentration 8 Think about it a lot 
3 Look different 23 Miss studies/job for 
treatment 
10 Avoid new people 
4 Lonely 24 Future career 12 Unfriendly comments 
6 People stare at you 27 Pain/discomfort 13 Family relationships 
7 Low confidence 28 Sleep 14 Friend relationships 
9 Embarrassed 29 Treatment difficult 15 Intimate relationships 
11 Uncomfortable with 
others 
  25 Family/friends lack of support 
16 Stop going places   26 Healthcare lack of support 
17 Clothes   30 Treatment side effects 
18 Swimming     
19 Communal facilities     
20 Cover-up     
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Table 4.  Mean T-QoL total and domain scores in the six most common skin conditions in the study 
group of 203 subjects. 
 
Diagnosis N Mean T4QoL  
scale score 
Range=0436 
Mean Domain 
1 score 
Range=04 
Mean Domain 
2 score 
Range=04 
Mean Domain 
3 score 
Range=04 
Acne 105 11.6 6.8 1.4 3.5 
Eczema 31 15.8 8.4 3.5 3.9 
Psoriasis 8 13.25 8.4 1.5 3.4 
Moles 13 7.3 4.4 0.8 2.2 
Non4specific 
dermatitis 
5 10.4 5.8 1.6 3.0 
Warts 6 12.7 6.5 2.3 3.8 
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